The Heart/X
Jul 14, 2025, 12:30
The Heart: Managing Warfarin-Induced Coagulopathy – New Insights into Handling Prolonged INR Levels
The Heart has published on its official X page:
“Management of Prolonged INR (Warfarin-Induced Coagulopathy)”
Effective management of warfarin-induced coagulopathy, characterized by prolonged INR, is crucial to mitigate bleeding risks. Recent updates highlight evidence-based strategies for timely INR reversal, emphasizing a balance between anticoagulation control and patient safety.
More detailed insights on this topic are available at Hemostasis Today.
American Society of Hematology
American Thrombosis and Hemostasis Network
Anticoagulant complications
Bleeding risk reduction
Coagulopathy guidelines
EHA
Emergency anticoagulation care
Hemostasis and Thrombosis Research Society
Hemostasis management
Hemostasis Today
INR reversal strategies
Prolonged INR management
The Heart
Vitamin K antagonists
Warfarin safety
Warfarin-induced coagulopathy
World Federation of Hemophilia
-
Mar 6, 2026, 16:51Priya Reehal: Highlighting The Central Role of Nurses in Cardio-Oncology
-
Mar 6, 2026, 16:50Rainer Kaiser: Blinatumomab Shows Remarkable Response in Multi-Refractory ITP and APS
-
Mar 6, 2026, 16:18Laila Shalabi: Clopidogrel, Aspirin, and the Role of PPIs in Coronary Artery Disease
-
Mar 6, 2026, 16:17Paul McKenzie: The Value of Gene Therapy in Bleeding Disorders
-
Mar 6, 2026, 16:15Basma El Homasany: The ‘Little Brain’ of the Heart and Its Role in Health
-
Mar 6, 2026, 16:14Jamal Rana: Family History and Polygenic Risk for Coronary Heart Disease
-
Mar 6, 2026, 15:43Kristy Ainslie: Breaking Down the Discovery and FDA Approval of Drug Carriers
-
Mar 6, 2026, 15:18Claudio Laudani: Efficacy and Safety of Colchicine for Secondary Prevention in Coronary Artery Disease
-
Mar 6, 2026, 15:09Chris Simon: Persona PLUS Receives FDA Clearance for Patent‑Protected Plasma Apheresis